Almirall opens the doors of its R&D centre to the biotech ZeClinics 27/02/2023 Healthcare Access to innovation Corporate Their incorporation into Almirall's R&D facilities is the first step in Almirall's plans to create a highly... Partners - Almirall
BCN HEALTH publishes a study reviewing economic evaluations and burden of disease studies ... 22/02/2023 Healthcare Access to innovation BCN HEALTH ha publicado el estudio 'Economic implications of endometriosis: A review' en la revista 'PharmacoEconomics' Partners - BCN Health
EU Pharmaceutical Law Forum Híbrido - Bruselas (Bélgica) & online Bélgica Del 23/05/2023 to 25/05/2023 Access to innovation Drug discovery
Business Forum: Investment Opportunities in Bulgaria – Chemical Industry and Biotechnology Barcelona España Del 01/03/2023 to 01/03/2023 Access to innovation
AptaTargets awarded €2.5 million grant from Spanish government to evaluate ApTOLL for acut... 23/01/2023 Healthcare Access to innovation Corporate The funds are from a competitive call through the 2021 State Programme to Promote Scientific-Technical Research and its... Partners - AptaTargets
Ysios Capital strengthens its team with internal promotions and a new Venture Partner 19/01/2023 Access to innovation Corporate Jordi Xiol has been promoted to Partner after joining Ysios Capital in 2019 Ysios is also incorporating Sanifit co... Partners - Ysios Capital Partners
BCN HEALTH has published 10 studies in 2022 assessing the incidence and costs of illness o... 19/01/2023 Healthcare Access to innovation Corporate BCN HEALTH has published 10 studies in 2022 assessing the incidence and cost of illness of different diseases in Spain. Partners - BCN Health
DIVERSA Technologies is driven by Innovation 19/01/2023 Access to innovation Corporate The Galician Innovation Agency has awarded DIVERSA through the InnovaPeme program to implement its innovation plan in... Partners - DIVERSA Technologies
The first orally administered biologic medicine based on intestinal microbiota: fiction or... 18/01/2023 Healthcare Access to innovation Corporate Mikrobiomik aims to be the first company in the world to commercialize the first biologic medicine based on intestinal... Partners - Mikrobiomik
